Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisphosphonate Therapy for Osteogenesis Imperfecta
NCT00159419Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Aug 1999
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial in osteogenesis imperfecta (OI) comparing Alendronate with Pamidronate (2 arms). Primary endpoint: Bone Mineral Density at 2 years. Started Aug 1999; status: completed.
02
Drugs
alendronatepamidronate
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT00159419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159419.